President & Chief Scientific Officer at PhRMetrix Inc. - White Plains, New York, United States
PhRMetrix Inc. is a US-based consultancy providing medical, scientific and trial design advice for Phase II and Phase III drug development for neurodegenerative, psychiatric and neurologic disease. PhRMetrix Inc. has worked with companies such as Eisai, Taisho and TEVA/Cephalon to further their drug development efforts.